Last reviewed · How we verify

NCT03529097

Evaluation of the Roll of IV Fluids in the Treatment of Renal Colic

Withdrawn Phase 4 Last updated 4 October 2021
What this trial tests

Phase 4 trial testing 0.9% Sodium-chloride in Renal Colic. Withdrawn.

Timeline
1 June 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorSheba Medical Center
PhasePhase 4
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Start date1 June 2018
Primary completion31 December 2019
Estimated completion31 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Sheba Medical Center

Who can join

18 and older, any sex, with Renal Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised controlled trial to evaluate the role of IV fluids in renal colic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of 0.9% Sodium-chloride

Trials testing the same drug.

Other recruiting trials for Renal Colic

Currently open trials in the same condition.

Other Sheba Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing